Claims for Patent: 8,075,911
✉ Email this page to a colleague
Summary for Patent: 8,075,911
Title: | Transparent transdermal nicotine delivery devices |
Abstract: | A transparent transdermal delivery device for delivering nicotine which has an Opacity Index of less than 48.6%. |
Inventor(s): | Gale; Robert M. (Los Altos, CA) |
Assignee: | Alza Corporation (Mt. View, CA) |
Application Number: | 11/841,789 |
Patent Claims: |
1. A device for transdermal administration of nicotine, comprising: a polymeric backing layer comprising a material selected from the group consisting of PET/EVA laminates,
HDPE/EAA/nylon/EAA multilaminate and a film comprising a graft copolymer formed from 73-77% acrylonitrile and from 23-27% methyl acrylate copolymerized in the presence of 8-10 parts by weight of butadiene/acrylonitrile copolymers containing 70% by weight
of polymer units derived from butadiene, a drug reservoir layer containing nicotine carried by the backing layer, and an adhesive for maintaining the device on the skin, wherein the device provides delivery of nicotine for a period of 18-24 hours and, as
applied to the skin, exhibits an Opacity Index of less than 48.6% to permit the skin to which the device is applied to be visible through the device.
2. The device of claim 1 wherein the backing layer has a nicotine permeability of less than 1.0 .mu.g/cm.sup.2hr. 3. The device of claim 1, further wherein the Opacity Index of the device is less than 35.11%. 4. The device of claim 3, wherein the Opacity Index of the device is less than 20%. 5. The device of claim 1 wherein the backing comprises a PET/EVA laminate. 6. A device for transdermal nicotine administration, comprising: a laminate including a polymeric backing layer comprising a material selected from the group consisting of PET/EVA laminates, HDPE/EAA/nylon/EAA multilaminate and a film comprising a graft copolymer formed from 73-77% acrylonitrile and from 23-27% methyl acrylate copolymerized in the presence of 8-10 parts by weight of butadiene/acrylonitrile copolymers containing 70% by weight of polymer units derived from butadiene, a nicotine reservoir layer having nicotine carried by the backing layer, a rate control membrane near the nicotine reservoir to face the skin for controlling nicotine delivery to the skin, and adhesive for maintaining the device on the skin, wherein the device provides delivery of nicotine for a period of 18-24 hours and, as applied to the skin, exhibits an Opacity Index of less than 48.6% to permit the skin to which the device is applied to be visible through the device. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.